RBR-67ynvt
Recruiting
未知
Efficacy and safety of Botulinum Toxin in the treatment of spasticity in patients with Tropical spastic paraparesis
Hospital Universitário Professor Edgard Santos0 sitesFebruary 20, 2020
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Hospital Universitário Professor Edgard Santos
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Individuals over 18 years old; both sexes; diagnosed with tropical spastic paraparesis, confirmed with Elisa and Western Blot tests; who have not used botulinum toxin to treat spasticity
Exclusion Criteria
- •individuals who are pregnant; bleeding disorders; with an infectious skin lesion at the injection site; other neurological diseases
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
How safe is the use of Botulinum Toxin type A in the treatment of Masseter Hypertrophy?Masseter muscleSkeletal Muscle HypertrophyRBR-7tdjcn5Faculdade Ingá - UNINGÁ/Paraná
Recruiting
Phase 3
Efficacy Of Botulinum Toxin In The Treatment Of AcneAcne vulgaris.Acne vulgarisL70.0IRCT20230529058336N1Tehran University of Medical Sciences30
Active, not recruiting
Not Applicable
Evaluation of the effect of Botulinum Toxin as a treatment for Male Pattern BaldnessAndrogenetic AlopeciaC17.800.329.937RBR-5z2rr58Faculdade de Ciências Médicas - Universidade do Estado do Rio de Janeiro
Active, not recruiting
Not Applicable
Study of effect and duration of botox in the treatment of gnash or clench your teethpatients wit bruxismC07.793.099RBR-39ght5niversidade Ibirapuera
Active, not recruiting
Not Applicable
EFFICACY AND SAFETYOF BOTULINUM TOXIN THERAPY ON UPPER LIMB SPASTICITY IN INFLAMMATORY AND DEMIELINIZZATING DISEASE OF CENTRAL NERVOUS SYSTEM. - NDmultiple sclerosisMedDRA version: 9.1Level: HLTClassification code 10052785Term: Multiple sclerosis acute and progressiveEUCTR2007-006268-32-ITOSPEDALE S. RAFFAELE